The Feinstein Institutes for Medical Research has been awarded $3 million from the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), in ...
By David Stephen The sweeping and aggressive cuts to research funding at the National Institutes of Health [NIH] suggests ...
About the National Institute of Neurological Disorders and Stroke (NINDS): NINDS is the nation’s leading funder of research ...
In a preclinical study, rodents treated with uric acid showed improved long-term outcomes after acute ischemic stroke. The ...
Standardizing data collection in ME/CFS research through Common Data Elements is a crucial step toward improving diagnosis, ...
A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...
NIH-Funded Research Team Engineers New Drug Targeting Pain Sensation Pathway with Implications for Chronic Pain Treatment ...
A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem ...
The neurotransmitter glutamate is essential for regulating everything from mood to memory, but it can also encourage a toxic buildup of protein, which can contribute to Alzheimer's and related ...
Dozens of NIH study sections — meetings in which panels of expert scientists consider which research projects the agency should support — have been canceled in recent weeks, after the Trump ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback